Market Cap 165.97M
Revenue (ttm) 10.68M
Net Income (ttm) -27.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -260.49%
Debt to Equity Ratio 0.08
Volume 41,700
Avg Vol 76,332
Day's Range N/A - N/A
Shares Out 30.04M
Stochastic %K 46%
Beta 0.68
Analysts Strong Sell
Price Target $15.31

Latest News on PROF

Profound Medical Corp. (PROF) Q1 2024 Earnings Call Transcript

May 11, 2024, 1:47 PM EDT - 11 months ago

Profound Medical Corp. (PROF) Q1 2024 Earnings Call Transcript


Profound Medical Announces Non-Brokered Private Placement

Jan 16, 2024, 4:30 PM EST - 1 year ago

Profound Medical Announces Non-Brokered Private Placement